Cochrane Summaries

Trusted evidence. Informed decisions. Better health.

Nicotine for schizophrenia

Punnoose S, Belgamwar MR
Published Online: 
15 February 2012

People with schizophrenia tend to smoke heavily and to a greater extent when compared to other patient groups. In this review we aimed to investigate this by searching for good quality evidence from randomised controlled trials on the effect of nicotine for schizophrenia, and/or to ascertain whether nicotine modifies the side effects of antipsychotics. Unfortunately we found no trials that met our inclusion criteria to support or refute this. There is a need for good quality randomised controlled trials that investigate the effects of nicotine for schizophrenia.

This record should be cited as: 
Punnoose S, Belgamwar MR. Nicotine for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD004838. DOI: 10.1002/14651858.CD004838.pub2
Assessed as up to date: 
1 September 2005